Filariasis Global Clinical Trials Review, H1, 2015

Filariasis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2686CTIDB
  • |
  • Pages: 72
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Filariasis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Filariasis Global Clinical Trials Review, H1, 2015" provides data on the Filariasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Filariasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Filariasis . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Filariasis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Filariasis to Infectious Disease Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Filariasis to Infectious Disease Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials in E7 Countries by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Unaccomplished Trials of Filariasis 24

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Filariasis Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

International Trachoma Initiative 32

Clinical Trial Overview of International Trachoma Initiative 32

GlaxoSmithKline plc 33

Clinical Trial Overview of GlaxoSmithKline plc 33

Clinical Trial Overview of Top Institutes / Government 34

The National Institute of Allergy and Infectious Diseases 34

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 34

VolkswagenStiftung 35

Clinical Trial Overview of VolkswagenStiftung 35

Washington University School of Medicine 36

Clinical Trial Overview of Washington University School of Medicine 36

DBL-Centre for Health Research and Development 37

Clinical Trial Overview of DBL-Centre for Health Research and Development 37

Liverpool School of Tropical Medicine 38

Clinical Trial Overview of Liverpool School of Tropical Medicine 38

Central Council for Research in Homoeopathy 39

Clinical Trial Overview of Central Council for Research in Homoeopathy 39

Central Drug Research Institute 40

Clinical Trial Overview of Central Drug Research Institute 40

Centre d'Appui a la lutte contre la Maladie 41

Clinical Trial Overview of Centre d'Appui a la lutte contre la Maladie 41

Emory University 42

Clinical Trial Overview of Emory University 42

European Commission 43

Clinical Trial Overview of European Commission 43

Five Key Clinical Profiles 44

Appendix 70

Abbreviations 70

Definitions 70

Research Methodology 71

Secondary Research 71

About GlobalData 72

Contact Us 72

Disclaimer 72

Source 72

List of Figures

Filariasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Filariasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Filariasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Filariasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Filariasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11

Filariasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Proportion of Filariasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 14

Filariasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Filariasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Filariasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 17

Filariasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Filariasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Filariasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20

Filariasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21

Filariasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Filariasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Filariasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Filariasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Filariasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Filariasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Filariasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 71

List of Tables

Filariasis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Filariasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Filariasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Filariasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Filariasis Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11

Filariasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Filariasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Proportion of Filariasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 14

Filariasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Filariasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Filariasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 17

Filariasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Filariasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Filariasis Therapeutics, Global, Clinical Trials by Phase, 2015* 20

Filariasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21

Filariasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Filariasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Filariasis Therapeutics, Global, Suspended Clinical Trials, 2015* 24

Filariasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Filariasis Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Filariasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Filariasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Filariasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Filariasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Filariasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by International Trachoma Initiative, 2015* 32

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 33

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 34

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by VolkswagenStiftung, 2015* 35

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2015* 36

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by DBL-Centre for Health Research and Development, 2015* 37

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Liverpool School of Tropical Medicine, 2015* 38

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Council for Research in Homoeopathy, 2015* 39

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Drug Research Institute, 2015* 40

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre d'Appui a la lutte contre la Maladie, 2015* 41

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015* 42

Filariasis Therapeutics Clinical Trials Market, Global, Clinical Trials by European Commission, 2015* 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

International Trachoma Initiative

GlaxoSmithKline plc

Filariasis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Filariasis , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 161450
Site License
USD 5000 INR 322900
Corporate User License
USD 7500 INR 484350

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com